MFAM
MRNA icon

Motley Fool Asset Management’s Moderna MRNA Stock Holding History

Motley Fool Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Buy
6,721
+194
+3% +$10K 0.02% 187
2026
Q1 		$332K Buy
+6,527
New +$305K 0.01% 205
2025
Q1 		– Sell
-5,668
Closed -$236K – 236
2024
Q4 		$236K Sell
5,668
-9,800
-63% -$468K 0.01% 212
2024
Q3 		$989K Buy
15,468
+578
+4% +$53.1K 0.06% 155
2024
Q2 		$1.73M Buy
14,890
+3,592
+32% +$455K 0.11% 128
2024
Q1 		$1.2M Buy
11,298
+812
+8% +$81.8K 0.08% 154
2023
Q4 		$1.04M Buy
10,486
+684
+7% +$57.5K 0.08% 150
2023
Q3 		$1.01M Buy
9,802
+738
+8% +$82.3K 0.08% 147
2023
Q2 		$1.1M Buy
+9,064
New +$1.21M 0.1% 134
2023
Q1 		– Sell
-8,632
Closed -$1.55M – 170
2022
Q4 		$1.55M Sell
8,632
-520
-6% -$85K 0.17% 98
2022
Q3 		$1.08M Sell
9,152
-54
-0.6% -$8.19K 0.11% 122
2022
Q2 		$1.43M Sell
9,206
-801
-8% -$114K 0.13% 110
2022
Q1 		$1.72M Sell
10,007
-458
-4% -$77.1K 0.13% 114
2021
Q4 		$2.66M Sell
10,465
-603
-5% -$176K 0.17% 97
2021
Q3 		$4.26M Buy
11,068
+2,379
+27% +$877K 0.28% 80
2021
Q2 		$2.04M Sell
8,689
-1,481
-15% -$265K 0.13% 109
2021
Q1 		$1.33M Buy
+10,170
New +$1.47M 0.1% 119

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Motley Fool Asset Management's MRNA Position: Q2 2026 in Review

Motley Fool Asset Management increased its Moderna (MRNA) stake by 3% in Q2 2026, buying an estimated $10K and bringing the position to 6,721 shares worth $471K. The position accounts for 0.02% of the portfolio, ranked #187.

Motley Fool Asset Management first reported a position in MRNA in Q1 2021 and has held it in 17 quarters since. The position peaked at $4.26M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Motley Fool Asset Management held 6,721 shares of Moderna worth $471K as of Q2 2026.
  • Motley Fool Asset Management bought 194 Moderna shares in Q2 2026, an estimated $10K.
  • Moderna made up 0.02% of Motley Fool Asset Management's portfolio in Q2 2026, its #187 holding.
  • Motley Fool Asset Management first reported a position in Moderna in Q1 2021 and has held it in 17 quarters since.
  • Motley Fool Asset Management's Moderna position peaked at $4.26M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.